XML 37 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2020
Stockholders' Equity Note [Abstract]  
Schedule of restricted common stock
   Number of
shares
   Weighted
average
grant date
fair
value
 
Non–vested at January 1, 2020   
-
   $
-
 
Granted   715,929   $9.30 
Vested   (238,643)  $9.30 
Non–vested at December 31, 2020   477,286   $9.30 

 

Schedule of restricted stock units
   Number of
shares
   Weighted average
grant date
fair
value
 
Non–vested at January 1, 2020   
-
   $
-
 
Granted   1,676,447   $2.52 
Vested   (176,514)  $2.80 
Forfeited   
-
    
-
 
Non–vested at December 31, 2020   1,499,933   $2.49 

 

Schedule of warrant activity
   Number of Shares   Weighted Average Exercise Price (USD)   Weighted Average Contractual Life (years)   Intrinsic Value (USD) 
Outstanding - January 1, 2020   
-
   $
-
               
Issued in connection with Business Combination   17,400,000   $11.50    4.50      
Issued in connection with November 2020 Public Offering   17,857,142   $1.40    4.88      
Issued in connection with November 2020 overallotment   2,678,571   $1.40    4.88      
Issued in connection with IRG November Note Conversion   10,036,925   $1.40    4.99      
Outstanding – December 31, 2020   47,972,638   $5.06    4.76   $
-
 
Exercisable – December 31, 2020   37,935,713   $6.03    4.70   $
-